Inter Scientific Supports the EU Certification for First Handheld Liquid Inhalation Device
Home News Inter Scientific Supports the EU Certification for First Handheld Liquid Inhalation Device

Inter Scientific Supports the EU Certification for First Handheld Liquid Inhalation Device

OCTOBER 8, 2025 BHH News

Inter Scientific is pleased to announce its role, in collaboration with Jupiter Research LLC, as the regulatory partner for the first handheld Liquid Inhalation Device to receive regulatory approval under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone marks a significant step forward in the medical device landscape and opens the door for wider global access to innovative inhalation technologies.

Jupiter Research, a pioneering company in the liquid vaporizer space, identified early in its development journey the importance of an expert regulatory partner. After an initial review process, Jupiter selected Inter Scientific based on its ability to meet the demands and complexity of the EU MDR. This decision proved instrumental in Jupiter’s successful regulatory approval.

“Jupiter recognised very early in the process that external support would be beneficial,” stated Jupiter’s Senior Director of Engineering, Jordan Walker. “We chose Inter Scientific based on their expertise and felt they were efficient and professional throughout the contract, helping us achieve our goals and gain regulatory approval.”

Walker continued, “Inter Scientific provided expertise in the creation of the device’s comprehensive Technical File, development of the required Quality Management System documentation, and delivery of tailored educational services to Jupiter’s internal teams. This approach enabled a streamlined path to regulatory compliance.”

David Lawson, Executive Director at Inter Scientific, commented:
“At every stage of this rigorous certification process, Inter Scientific maintained a customer-focused approach, working closely with the Jupiter team and delivering timely, professional, and accurate support. We’re proud to be recognised as a key contributor to this success and look forward to building on this achievement through continued collaboration on future regulatory initiatives.”

Inter Scientific’s in-depth understanding of the regulatory framework helped Jupiter design the device in line with medical classification requirements, prepare the necessary documentation, and respond effectively to regulatory feedback, which resulted in the successful approval of a first of its kind device now poised to make its mark in global healthcare.

Discover more 

March 12, 2026 BHH News
TPM Science’s Strategic Approaches to Strong Regulatory Writing
In today’s global clinical development environment, regulatory operations function within a framework defined by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and enforced by authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Within this landscape, documentation quality can directly influence review timelines, the number of clarification requests, and ultimately, regulatory outcomes.
Read more
March 12, 2026 BHH News Events
Doctoralia’s Women in Health 2026 brings together experts shaping the future of women’s health
The event will gather healthcare professionals in Barcelona to discuss entrepreneurship, multidisciplinary care, and new approaches to women’s wellbeing.
Read more
March 12, 2026 BHH News Events
The Health Data Space. Challenges and opportunities
The European Health Data Space will mark a turning point in the way we share, analyze, and use health data in Spain and across Europe. 
Read more
March 12, 2026 BHH News Events
Designing Healthcare from Within: TISAC Launches the First Edition of the Healthcare Service Design Course
Healthcare systems are undergoing a period of profound transformation. However, many organizations continue to face structural challenges: fragmented processes, improvable experiences, and teams working under constant pressure.
Read more
March 12, 2026 BHH News Events
Scilife Training | The Cost of Inaction: what delaying quality modernization is really costing you
Your quality system modernization keeps getting pushed back, but at what cost? In this session, Scilife will uncover where the cost of inaction shows up in daily operations and leadership decisions, and why maintaining the status quo may be riskier than it seems.
Read more
March 12, 2026 BHH News Events
Join Health Proc Europe in Montréal: European Delegation to Canada 2026
Montréal, Canada  |  27–30 April 2026 We are excited to share an opportunity for our members to be part of an international initiative
Read more
March 03, 2026 BHH News Events
This International Women’s Day, we are creating space for a conversation that’s long overdue
An expert roundtable in Barcelona for International Women’s Day exploring female sexuality through Western medicine, Eastern wisdom, and FemTech innovation.
Read more
February 27, 2026 BHH News
BWAW 2026: Celebrating Female Leadership Across Industries
Join the sixth edition of the Barcelona Women Acceleration Week to connect with leaders shaping innovation.
Read more
February 27, 2026 BHH News Events
EvoMed Webinar: "A new approach to Clinical Adoption"
On 3 March, from 5:00–6:00 PM CET, a dedicated webinar will explore how regulation in HealthTech can drive AI innovation while ensuring safety, compliance, and traceability.
Read more
February 27, 2026 BHH News Events
6th Call for Catalonia Exponential Leaders 2026 (CEL’26)
ACCIÓ has launched the 6th edition of the Catalonia Exponential Leaders (CEL) program, aimed at identifying the 10 most disruptive companies of 2026. We are looking for bold, innovative, and disruptive companies with the potential for exponential growth.
Read more